Treatment patterns, outcomes and clinical characteristics in advanced renal cell carcinoma: a real-world US study.

Assessing treatment patterns, outcomes and clinical characteristics in advanced renal cell carcinoma clinical practice. A US cross-sectional physician survey conducted February-September 2019. Surveyed physicians reported first-line treatment of 445 patients involving tyrosine kinase inhibitor monotherapy (51.

Real-world treatment patterns in patients with advanced (stage III-IV) ovarian cancer in the USA and Europe.

To analyze real-world data relating to treatment decision-making in stage III-IV ovarian cancer (OC). Real world data were collected from a survey of physicians and their patients (n = 2413) across Europe and the USA in 2017-2018. 49% had stage IVb disease.